UTSouthwestern Medical Center has received a groundbreaking ARPA-H award to develop a revolutionary solution for liver disease patients. The project, known as Vascularized Immunocompetent Tissue as an Alternative Liver (VITAL), aims to create functioning artificial livers using patients' own cells and 3D printing technology. If successful, this approach could potentially transform the field of organ transplantation, offering a personalized and patient-specific solution. The project is led by Dr. Muhammad Rizwan, an Assistant Professor of Biomedical Engineering and Ophthalmology at UTSouthwestern, and is supported by a team of experts across various disciplines. The goal is to address the critical shortage of donor livers and the associated challenges, such as the need for lifelong immunosuppression and the high cost of liver transplantation. By utilizing patient-derived cells and innovative 3D printing techniques, the VITAL project has the potential to create fully functional artificial livers, which could be used for in vitro drug testing, research, and potentially even transplantation without the need for immunosuppression. This groundbreaking research is a testament to the power of biomedical innovation and the dedication of scientists and clinicians at UTSouthwestern.
